Novartis
NVS
NVS
1,027 hedge funds and large institutions have $22.4B invested in Novartis in 2018 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 359 increasing their positions, 368 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,027
Holders Change
+41
Holders Change %
+4.16%
% of All Funds
23.52%
Holding in Top 10
22
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+69.23%
% of All Funds
0.5%
New
91
Increased
359
Reduced
368
Closed
44
Calls
$89.4M
Puts
$63.6M
Net Calls
+$25.8M
Net Calls Change
-$44.1M
Top Buyers
Top Sellers
| 1 |
Renaissance Technologies
New York
|
$256M |
| 2 |
D.E. Shaw & Co
New York
|
$17M |
| 3 |
Franklin Resources
San Mateo,
California
|
$1.3B |
| 4 |
Two Sigma Investments
New York
|
$12.5M |
| 5 |
BBHC
Brown Brothers Harriman & Co
New York
|
$648M |
